Alice Shaw is Being Named Dana-Farber Cancer Institute’s Next Chair of the Department of Medical Oncology
Dana-Farber Cancer Institute shared a post on LinkedIn:
“Please join us in congratulating Alice Shaw on being named our next Chair of the Department of Medical Oncology.
As Chair of the Department of Medical Oncology, Shaw will oversee more than 300 faculty and more than 80 cancer research laboratories, and will drive the strategic direction for the department’s clinical, research and educational initiatives. Shaw will remain Chief of Strategic Partnerships and a member of the Executive Leadership Team, and will continue to co-lead our Center for RAS Therapeutics.
“Dana-Farber’s Medical Oncology department provides world-class care and support for our patients, while leading critical research that is advancing cancer treatment in Boston and around the world,” said Benjamin L. Ebert, MD, PhD, president and CEO. “I am thrilled that Alice will lead the department during this pivotal time for Dana-Farber. She brings exceptional leadership and a visionary approach to accelerating cancer care for our patients and their families.”
More posts featuring Alice Shaw.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023